EBS:NYE-Emergent Biosolutions Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 10.28

Change

+0.01 (+0.10)%

Market Cap

N/A

Volume

1.13M

Analyst Target

USD 112.29
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-07 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

-2.41 (-1.45%)

USD 74.37B
HLN Haleon plc

+0.01 (+0.11%)

USD 44.13B
TAK Takeda Pharmaceutical Co Ltd A..

+0.05 (+0.38%)

USD 42.24B
RDY Dr. Reddy’s Laboratories Ltd..

+0.25 (+1.62%)

USD 13.11B
CTLT Catalent Inc

N/A

USD 11.52B
ELAN Elanco Animal Health

-0.12 (-1.01%)

USD 5.75B
AMRX Amneal Pharmaceuticals, Inc. C..

+0.10 (+1.29%)

USD 3.59B
BHC Bausch Health Companies Inc

+0.05 (+0.64%)

USD 2.75B
CPHI China Pharma Holdings Inc

-0.03 (-10.38%)

USD 3.69M
YCBD cbdMD Inc

-0.06 (-10.59%)

USD 1.96M

ETFs Containing EBS

BNKE:LSE Lyxor EURO STOXX Banks UC.. 3.04 % 0.00 %

+0.12 (+0.13%)

USD 0.30M
BINV 2023 ETF Series Trust - B.. 2.15 % 0.00 %

+0.04 (+0.13%)

USD 0.14B
EMUM:SW iShares MSCI EMU Mid Cap .. 1.93 % 0.00 %

-0.10 (0.13%)

USD 0.14B
FEUZ First Trust Eurozone Alph.. 1.35 % 0.80 %

N/A

USD 0.02B
LDEG:LSE L&G Quality Equity Divide.. 1.30 % 0.00 %

-0.50 (0.13%)

N/A
LDEU:LSE L&G Quality Equity Divide.. 1.30 % 0.00 %

+0.01 (+0.13%)

USD 0.04B
FEP First Trust Europe AlphaD.. 1.01 % 0.80 %

-0.16 (0.13%)

USD 0.18B
EUMD:LSE iShares MSCI Europe Mid C.. 0.00 % 0.00 %

-0.06 (0.13%)

USD 0.27B
FEUZ:LSE First Trust Eurozone Alph.. 0.00 % 0.00 %

-1.00 (0.13%)

USD 0.06B
FEUD:LSE First Trust Eurozone Alph.. 0.00 % 0.00 %

-0.25 (0.13%)

USD 0.01B
IS3H:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
IS3H:XETRA iShares MSCI EMU Mid Cap .. 0.00 % 0.00 %

-0.06 (0.13%)

USD 0.13B
FTEU:LSE First Trust Eurozone Alph.. 0.00 % 0.00 %

-0.11 (0.13%)

USD 0.06B
FTGE:XETRA First Trust Eurozone Alph.. 0.00 % 0.00 %

+0.20 (+0.13%)

USD 0.08B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.53% 86% B+ 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.53% 86% B+ 95% A
Trailing 12 Months  
Capital Gain 394.23% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 394.23% 100% F 100% F
Trailing 5 Years  
Capital Gain -81.86% 21% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -81.86% 21% F 3% F
Average Annual (5 Year Horizon)  
Capital Gain -19.67% 7% C- 2% F
Dividend Return -19.67% 7% C- 2% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 98.41% 20% F 9% A-
Risk Adjusted Return -19.99% 20% F 11% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector